Back to top
more

Cronos Group (CRON)

(Real Time Quote from BATS)

$2.42 USD

2.42
75,182

+0.04 (1.68%)

Updated Jul 12, 2024 10:16 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.15%
2Buy17.88%
3Hold9.47%
4Sell5.14%
5Strong Sell2.57%
S&P50011.11%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

F Value F Growth B Momentum F VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 40% (151 out of 250)

Industry: Medical - Drugs

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Altria (MO) Confirms Deal With JUUL, Unveils Savings Plan

by Zacks Equity Research

Altria's (MO) deal with JUUL to boost strength in reduced risk products realm. Further, the company reiterates earnings view for 2018.

Cronos Group (CRON) Stock Moves -0.36%: What You Should Know

by Zacks Equity Research

Cronos Group (CRON) closed at $11.13 in the latest trading session, marking a -0.36% move from the prior day.

Altria Likely to Invest in Juul to Bolster E-Cigarettes Unit

by Zacks Equity Research

Altria (MO) is undertaking efforts to boost smokeless offerings. Per market reports, the company is considering an investment in Juul.

Can Altria (MO) Rebound From a Terrible 2018?

by Zacks Equity Research

Stringent FDA regulations have led to fading cigarette sales that are plaguing the performance of Altria. Nevertheless, growth in RRPs looks encouraging.

Cronos Group (CRON) Stock Moves -0.88%: What You Should Know

by Zacks Equity Research

Cronos Group (CRON) closed at $11.28 in the latest trading session, marking a -0.88% move from the prior day.

Sanghamitra Saha headshot

4 Reasons Why Pot Stocks & ETF Could Be on a High in 2019

by Sanghamitra Saha

These are the factors that could send marijuana stocks and ETF high in 2019.

Ryan McQueeney headshot

3 Pot Stocks to Watch on Farm Bill & News from Trump, May, Retail Earnings

by Ryan McQueeney

Ryan McQueeney discusses President Trump's latest comments on the trade war and the impending vote of confidence facing U.K. Prime Minister Theresa May. He also recaps earnings results from the retail sector. Later, he highlights three cannabis stocks to watch as the farm bill passes.

Implied Volatility Surging for Cronos Group (CRON) Stock Options

by Zacks Equity Research

Investors need to pay close attention to Cronos Group (CRON) stock based on the movements in the options market lately.

    Ryan McQueeney headshot

    Canopy Growth (CGC) Gains on Hemp Legalization, Institutional Interest

    by Ryan McQueeney

    Shares of Canopy Growth (CGC) were up more than 6% in late afternoon trading Tuesday, as investors expressed optimism about the Senate's hemp legalization bill and management's comments about interest from institutional investors.

    The Zacks Analyst Blog Highlights: Altria, Cronos, Constellation, Canopy Growth and ETFMG Alternative Harvest

    by Zacks Equity Research

    The Zacks Analyst Blog Highlights: Altria, Cronos, Constellation, Canopy Growth and ETFMG Alternative Harvest

    Cronos Group (CRON) Soars on C$2.4B Investment from Altria

    by Zacks Equity Research

    Cronos Group (CRON) receives a significant boost with C$2.4-billion equity investment from tobacco giant Altria Group.

    Sweta Killa headshot

    Cronos-Altria Deal Boost Marijuana ETF: Will This Continue?

    by Sweta Killa

    Altria investment in Canadian cannabis producer Cronos sparked a rally in the broad cannabis sector and the its ETF. Will the trend continue?

    Company News For Dec 10, 2018

    by Zacks Equity Research

    Companies In The News Are: BIG,ULTA,CRON,MO,LULU

    Ryan McQueeney headshot

    Are There Any Dividend-Paying Cannabis Stocks?

    by Ryan McQueeney

    Cannabis stocks have been one of the investing world's top stories in 2018, but for many, these speculative plays are far too unpredictable. Are there any stable, dividend-paying marijuana stocks to buy right now?

    Company News For Dec 5, 2018

    by Zacks Equity Research

    Companies In The News Are: DG,AZO,RH,CRON,MO

    Ryan McQueeney headshot

    Why Tesla Is a Buy-Ranked Stock & the Latest Cannabis Industry Buzz

    by Ryan McQueeney

    Ryan McQueeney discusses President Trump's "Tariff Man" tweets and recaps the latest news from the cannabis industry. Later, he chats with Brian Bolan about Tesla (TSLA), a Zacks Rank #1 (Strong Buy) stock.

    Ryan McQueeney headshot

    Why Cannabis Stocks CRON & APHA Are Moving in Opposite Directions

    by Ryan McQueeney

    Shares of Cronos Group (CRON) and Aphria (APHA) extended their recent moves in opposite directions on Tuesday morning, as investors continued to digest major headlines related to the popular cannabis companies.

    Altria Likely to Venture Into Cannabis Space With Cronos Deal

    by Zacks Equity Research

    Per sources, Altria (MO) is likely to explore opportunities in the cannabis space through a deal with Cronos.

    Nitish Marwah headshot

    Legal Pot Shops & Likely IPOs: Is Hemp the Next Big Thing?

    by Nitish Marwah

    Increasing tolerance and gradual legalization of marijuana has been an increasing trend across America.

    Cronos Group (CRON) Stock Moves -0.49%: What You Should Know

    by Zacks Equity Research

    Cronos Group (CRON) closed the most recent trading day at $8.20, moving -0.49% from the previous trading session.

    Sanghamitra Saha headshot

    Top and Flop ETFs of Last Week

    by Sanghamitra Saha

    Inside the winning and losing ETFs of the last week.

    Sanghamitra Saha headshot

    What Went Wrong With the Marijuana ETF on Wednesday?

    by Sanghamitra Saha

    Downbeat earnings have weighed on the marijuana ETF lately. Should you buy the dip or wait on the sidelines?

    Ryan McQueeney headshot

    Cannabis Stocks Reporting Earnings & News from HD, AAPL, TSN

    by Ryan McQueeney

    Ryan McQueeney discusses the latest trade war developments and recaps earnings results from Home Depot and Tyson Foods. He also touches on Apple's supplier concerns. Later, the host chats with Dave Bartosiak about the marijuana stocks reporting earnings this week.

    Cronos (CRON) to Report Q3 Earnings: What's in the Offing?

    by Zacks Equity Research

    Cronos' (CRON) third-quarter results are likely benefit from the company's collaboration initiatives to become one of the most promising cannabis company.

    Tracey Ryniec headshot

    The Earnings Charts of 3 Top Cannabis Stocks

    by Tracey Ryniec

    The cannabis stocks are hot but will their earnings reports be too?